GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

US FDA guidance on biosimilars may be imminent

27/9/2011

The U.S. Food and Drug Administration (FDA) appears to be on the verge of issuing long-awaiting guidelines for the development of generic versions of complex biotechnology medicines.  More...

 

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Stem Cells and Autism
18 September 2011